🔎 Trials Near Me

Akèy › Kansè (tout kalite) › Indiana › Indianapolis

Etid klinik pou Kansè (tout kalite) nan Indianapolis, IN

24 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Daily Hand-Held Vibration Therapy

Ap rekrite
  • Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
  • IU Health Joe & Shelly Schwarz Cancer Center, Indianapolis
  • Indiana University Health West, Avon · 13 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT04207437

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Ap rekriteEtid obsèvasyon
  • Indiana University, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Ap rekriteFaz 3
  • Franciscan Health Oncology and Hematology Specialists, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06901531

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Ap rekriteFaz 3
  • Franciscan St. Francis Health /ID# 279788, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07365241

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Ap rekriteFaz 2
  • Community Health Network (The University of Texas MD Anderson Cancer Center), Indianapolis
Laj 12 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02693535

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Ap rekriteFaz 1/2
  • Community Health Network, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Ap rekriteFaz 2/3
  • IN Univ Simon Cancer Center, Indianapolis
  • Franciscan Health Indianapolis, Indianapolis
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT03435796

Collection of Tissue Samples for Cancer Research

Ap rekriteEtid obsèvasyon
  • Indiana University - Purdue, Indianapolis
2 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT00900198

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • Community Cancer Center North, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Ap rekriteFaz 2
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07169851

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Riley Hospital for Children, Indianapolis
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Ap rekriteFaz 3
  • Franciscan Health, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05335928

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Ap rekriteFaz 3
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
  • Sidney and Lois Eskenazi Hospital, Indianapolis
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Ap rekriteFaz 1
  • Franciscan St. Francis Health /ID# 280928, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05650632

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Ap rekriteFaz 2
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT05852717

Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

Ap rekriteVolontè an sante akeyi
  • Indiana University School of Medicine, Indianapolis
Laj 18 a 99 · Tout sèks · Mizajou Jun 24, 2026 · NCT05346796

Childhood Cancer Survivor Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Indiana University/Riley Hospital for Children, Indianapolis
Tout laj · Tout sèks · Mizajou Jun 17, 2026 · NCT01120353

Galleri® in the Medicare Population.

Ap rekriteVolontè an sante akeyi
  • Community Health Network East, Indianapolis
  • Community Health Network South, Indianapolis
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05673018

The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities

Ap rekrite
  • University Hospital Clinical Research Center, Indianapolis
Laj 45 a 75 · Tout sèks · Mizajou May 14, 2026 · NCT07086833

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Ap rekrite
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Feb 19, 2026 · NCT02984761

GEMINI-NSCLC: NSCLC Biomarker Study

Ap rekriteEtid obsèvasyon
  • Community Health Network, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05236114

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • IU Simon Comprehensive Cancer Center, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2025 · NCT05970497

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Ap rekriteFaz 1/2
  • Community Health Network, Inc., Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2025 · NCT05669430

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Ap rekrite
  • Indiana University - Melvin and Bren Simon Cancer Center, Indianapolis
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • Franciscan Health Indianapolis, Indianapolis
Laj 18 ak plis · Tout sèks · Mizajou Nov 27, 2024 · NCT03860883

Etid Kansè (tout kalite) nan lòt vil

Lòt etid nan Indianapolis

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.